Managing Partner
Moriah Partners

Currently, Dr. Kosecoff is working in private equity to identify, select, mentor and manage health services and IT companies.

From 2002 to 2012, Dr. Kosecoff was a senior executive inside UnitedHealth Group-PacifiCare. Dr. Kosecoff joined UnitedHealth Group as part of its acquisition of PacifiCare Health Systems in 2005. At PacifiCare, Dr. Kosecoff served as Executive Vice President with responsibility for its specialty businesses, including its PBM, the Medicare Part D Drug Program, PacifiCare Behavioral Health (PBH), PacifiCare Dental & Vision (PDV), and Women’s Health Solutions. Upon joining United, Dr. Kosecoff was appointed CEO of Prescription Solutions (later renamed OptumRx) with responsibility for United’s PBM, Specialty Pharmacy and Consumer Health Products, providing services as of 2011 to more than 13 million members with annual revenue of $18.5 billion. In 2011, Dr. Kosecoff was named Senior Advisor for Optum to identify and develop new growth and collaborative opportunities. Optum encompasses the health services businesses of UnitedHealth Group, consisting of OptumHealth, OptumInsight and OptumRx.

Prior to joining UnitedHealth Group-PacifiCare, Dr. Kosecoff was founder, President and Chief Operating Officer of Protocare, a firm whose lines of business included the clinical development of drugs, devices, biopharmaceutical and nutritional products, and health services consulting. Dr. Kosecoff was co-founder and Co-CEO of Value Health Sciences (VHS), a wholly owned subsidiary of Value Health, Inc. (NYSE: VHI). VHS was the first company to combine medical sciences and information technology to reengineer the utilization review and approval process, saving payors millions while improving the quality of care.

Dr. Kosecoff served as Professor of Medicine and Public Health at the University of California, Los Angeles from 1975 to 2006.

In addition to her accomplishments as an entrepreneur, Dr. Kosecoff is a recognized expert in the areas of clinical and health services research, quality of care and technology assessment, disease management, and organization of the health care delivery system. She has published extensively in such journals as the New England Journal of Medicine, Journal of the American Medical Association, and the Annals of Internal Medicine. She has served as a consultant to the World Health Organization’s Global Quality Assessment Programs, on the Institute of Medicine’s Board of Health Care Services, the RAND Graduate School’s Board of Governors, and the Board of Directors for ALARIS (NYSE: AMI), CareFusion Corporation, City of Hope (emeritus board member), Pharmaceutical Care Management Association (PCMA), the Catalyst Western Region Advisory Board, and the Alliance for Aging Research, and was a member of the SAP America Executive Advisory Board.

Currently, Dr. Kosecoff sits on the board of directors of these public companies: GoodRx, Inc. (NASDAQ: GDRX); Houlihan Lokey, Inc. (NYSE: HLI); Sealed Air Corporation (NYSE: SEE); STERIS, plc (NYSE: STE); and TriNet Group, Inc. (NYSE: TNET) and these private companies: Alignment Healthcare; Independent Living Systems, LLC; InformedDNA; Intelligent Medical Objects (IMO); Ovia Health; Prolacta Bioscience; and Virgin Pulse.

Dr. Kosecoff holds a BA from the University of California, Los Angeles (UCLA), an MS in Applied Mathematics from Brown University, and a doctorate from UCLA.